Point72 Asset Management, L.P.

Position in VNDA — Vanda Pharmaceuticals Inc.

CIK 1603466 STAMFORD, CT

Position in VNDA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,905,535

+$788,907 QoQ

Shares Held

311,362

+92.7% QoQ

Ownership

0.515%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#27

of 172 holders

Holding Since

Mar 2020

8 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. VNDA ranks #101 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	4,473,478	$158,316,386
2	CYTK	Cytokinetics Inc	1,587,712	$135,257,185
3	BBIO	BridgeBio Pharma, Inc.	1,525,782	$113,640,243
4	AXSM	Axsome Therapeutics, Inc.	416,516	$101,950,621
5	LEGN	Legend Biotech Corp	3,076,124	$88,838,461
6	MDGL	Madrigal Pharmaceuticals, Inc.	137,029	$73,577,721
7	CELC	Celcuity Inc.	650,916	$68,098,831
8	ACAD	Acadia Pharmaceuticals Inc	2,433,168	$61,559,150

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,905,535	311,362	+92.7%	Shares	Defined	2026-08-14
2026-03-31	$1,116,628	161,596	+162.9%	Shares	Defined	2026-05-15
2025-12-31	$542,130	61,466	+6.9%	Shares	Defined	2026-02-17
2023-09-30	$248,356	57,490	-66.2%	Shares	Defined	2023-11-14
2020-12-31 ALXN	—	200,000	-85.4%	Shares	Defined	2021-02-16
2020-12-31	$2,233,800	170,000	—	Shares	Defined	2021-02-16
2020-09-30 ALXN	—	1,366,848	+12.8%	Shares	Defined	2020-11-16
2020-06-30 ALXN	—	1,211,342	+88.6%	Shares	Defined	2020-08-14
2020-03-31 ALXN	—	642,345	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.